<DOC>
	<DOCNO>NCT01804543</DOCNO>
	<brief_summary>Evaluation use ranolazine patient stable heart pain cardiac magnetic resonance imaging ( CMRI ) phosphorous-31 magnetic resonance spectroscopy ( 31P MRS ) . Subsequent test use modality show improve oxygen heart muscle .</brief_summary>
	<brief_title>Impact Ranolazine Myocardial Ischemia Detected High-Field 3T Cardiovascular Magnetic Resonance ( CMR ) Imaging P-31 Spectroscopy</brief_title>
	<detailed_description>Specific Aim : To determine patient stable coronary artery disease document inducible ischemia , treatment ranolazine lead reduce intracellular ischemia detect CMR perfusion image 31P spectroscopy 3 Tesla . Abstract : Despite many advance cardiovascular medicine patient coronary artery disease ( CAD ) , many patient United States continue morbidity mortality associate chronic stable angina . Ranolazine novel late sodium current inhibitor show effective treat angina patient chronic stable coronary artery disease without affect blood pressure heart rate product . It show reduce myocardial energy utilization enhance diastolic myocardial relaxation possibly increase myocardial blood flow . While ranolazine demonstrate improve size severity stress-induced myocardial perfusion defect , 's direct effect myocardial metabolism cellular ischemia test human . We propose use cardiac magnetic resonance imaging ( CMRI ) phosphorous-31 magnetic resonance spectroscopy ( 31P MRS ) evaluate patient chronic stable angina 4 week stable dose ranolazine detect change myocardial blood flow , ventricular function , myocardial scar metabolic parameter cellular ischemia .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Ranolazine</mesh_term>
	<criteria>1 . Age &gt; 18 year age stable angina pectoris anginal equivalent symptom ( e.g . atypical chest discomfort , dyspnea , easy fatigue ) AND 2 . Mild , moderate severe myocardial ischemia detect nuclear perfusion imaging ( exercise pharmacologic SPECT Rubidium PET ) , exercise stress echocardiography stress cardiac MRI OR Documentation obstructive coronary artery least one major coronary artery ( left anterior descending , circumflex right coronary artery ) least 70 % either conventional CT coronary angiography . 1 . Acute coronary syndrome include unstable angina non ST elevation myocardial infarction within last 60 day 2 . STelevation myocardial infarction within 60 day 3 . Equivocal myocardial ischemia noninvasive test study demonstrate reversible perfusion defect complicate significant attenuation artifact . 4 . Recent PCI within last 60 day 5 . Recent CABG within last 60 day 6 . Inability sign inform consent 7 . Patients take ranolazine within 30 day screen 8 . Patients take strong CYP3A inhibitor e.g . ketoconazole , itraconazole , clarithromycin , nefazodone , nelfinavir , ritonavir , indinavir , saquinavir 9 . Patients take inducer CYP3A e.g . rifampin , rifabutin , rifapentine , phenobarbital , phenytoin , carbamazepine , St. John 's wort 10 . Patients liver cirrhosis liver disease Grade B C ChildPugh Classification 11 . Prior allergic reaction intolerance ranolazine 12 . Patients history inherit acquire prolonged QT interval 13 . Moderate severe claustrophobia previous inability undergo MRI exam 14 . Patients implanted pacemaker internal cardiac defibrillator 15 . Patients metallic foreign body implant ( metal silver eye , cochlear implant ) aneurysm clip brain 16 . GFR &lt; 30 ml/m2 17 . Type 2 second degree heart block ( Mobitz II ) absence function permanent pacemaker . 18 . Sinus node dysfunction absence function permanent pacemaker . 19 . Patients take dipyridamole therapy . 20 . Active bronchospasm ( active asthma COPD active wheezing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>